Schon Pharmaceuticals Limited - Company Profile

It is a pharma public limited company based in Indore, Madhya Pradesh, India, established in 1994.
1994 Indore, Madhya Pradesh, India Active
Last Updated:
Access Report
About Schon Pharmaceuticals Limited

Schon Pharmaceuticals Limited, a active public limited company, was established on 30 September 1994 in Indore, Madhya Pradesh, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24231MP1994PLC007829. Registered under ROC Roc Gwalior. it is unlisted. It has an authorized capital of ₹1.25 Cr and a paid-up capital of ₹1.23 Cr.

Formerly known as Schon Pharmaceuticals Private Limited. It upholds a compliant status. Employing 77 professional, Its leadership includes Anil Bhatia (Director), Sunil Bhatia (Director), Pooja Bhatia (Director). Past directors included Surender Radhakrishnani Lachmandas, Pooja Bhatia, Rekha Bhatia. It holds ₹30.46 Cr open charges and ₹20.65 Cr settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at 145/2-A-B, Jambudi Hapsi Hatod Road, Indore, Madhya Pradesh, 453112.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24231MP1994PLC007829

  • Registration Number

    007829

  • Incorporation Date

    30 September 1994

  • Authorized Capital

    ₹1.25 Cr

  • Paid-Up Capital

    ₹1.23 Cr

  • ROC Code

    Roc Gwalior

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.25 Cr
  • Paid Up Capital ₹ 1.23 Cr
  • Company Age 31 Year, 5 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 30.46 Cr
  • Satisfied Charges ₹ 20.65 Cr
  • Revenue Growth **** 6.94%
  • Profit Growth **** 0.91%
  • Ebitda **** 3.07%
  • Net Worth 6.11%
  • Total Assets **** 1.89%
Company report

Schon Pharmaceuticals Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Schon Pharmaceuticals Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Schon Pharmaceuticals Limited?
Current Directors
Name Designation Appointment Date Status
Anil Bhatia Director 30 Sep 1994 Current
Sunil Bhatia Director 30 Sep 1994 Current
Pooja Bhatia Director 28 Aug 2023 Current
Prashant Singh Director 01 Apr 2014 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 01 Apr 2014 Past
Pramod Abcsdd Additional Director 29 Sep 2023 Past
Pramod Abcsdd Director - Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Schon Pharmaceuticals.

Schon Pharmaceuticals Limited, for the financial year ended 2024, experienced modest growth in revenue, with a 6.94% increase. The company also saw a slight improvement in profitability, with a 0.91% increase in profit. The company's net worth moved up by a moderate rise of 6.11%.

Schon Pharmaceuticals revenue growth over time
Schon Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 6.94%
*******
*******
*******
*******
Revenue from Operations
*******
 7.21%
*******
*******
*******
*******
Total Assets
*******
 1.89%
*******
*******
*******
*******
Profit or Loss
*******
 0.91%
*******
*******
*******
*******
Net Worth
*******
 6.11%
*******
*******
*******
*******
EBITDA
*******
 3.07%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Schon Pharmaceuticals?

In 2024, Schon Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹304,600,000.00

Satisfied Charges

₹206,500,000.00

Charges Breakdown by Lending Institutions
  • Axis Bank Limited : 23.40 Cr
  • Sidbi : 7.06 Cr
Latest Charge Details
Date Lender Amount Status
28 Feb 2025 Sidbi ₹1.10 Cr Open
23 Jan 2024 Sidbi ₹3.96 Cr Open
11 Jan 2022 Sidbi ₹2.00 Cr Open
26 Oct 2018 Axis Bank Limited ₹23.40 Cr Open
19 Nov 2015 Kotak Mahindra Bank Limited ₹8.00 Cr Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Schon Pharmaceuticals?

Schon Pharmaceuticals has a workforce of 77 employees as of Mar 26, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Schon Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Schon Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Schon Pharmaceuticals
Recent Activity within the Organization
  • Charges

    Progress on A charge with Axis Bank Limited of Rs. 23.40 Cr registered on 26 Oct 2018 with Charge ID 100220359 was modified on 14 Oct 2025. was documented.

  • Annual General Meeting

    Schon Pharmaceuticals Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    The activity Schon Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Gwalior. was completed.

  • Charges

    A charge with Sidbi amounted to Rs. 1.10 Cr with Charge ID 101060896 was registered on 28 Feb 2025. was recorded as a recent event.

  • Charges

    A charge with Sidbi amounted to Rs. 3.96 Cr with Charge ID 100853535 was registered on 23 Jan 2024. was recorded as a recent event.

  • Director Appointment

    The activity Pooja Bhatia was appointed as a Director was appointed as a Director on 28 Aug 2023 & has been associated with this company since 2 years 6 months . was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Schon Pharmaceuticals Limited?

The CIN of Schon Pharmaceuticals Limited is U24231MP1994PLC007829.

Where is Schon Pharmaceuticals Limited headquartered?

Schon Pharmaceuticals Limited is headquartered at 145/2-A-B, Jambudi Hapsi Hatod Road, Indore, Madhya Pradesh, 453112.

When was Schon Pharmaceuticals Limited incorporated?

Schon Pharmaceuticals Limited was incorporated on 30 September 1994.

Who are the current directors of Schon Pharmaceuticals Limited?

The current directors of Schon Pharmaceuticals Limited are

What is the primary industry of Schon Pharmaceuticals Limited?

The primary industry of Schon Pharmaceuticals Limited is Manufacturing.

Is Schon Pharmaceuticals Limited a listed company?

Schon Pharmaceuticals Limited is unlisted.

What is the capital structure of Schon Pharmaceuticals Limited?

The authorized capital of Schon Pharmaceuticals Limited is ₹1.25 Cr, and the paid-up capital is ₹1.23 Cr.

What is the compliance status of Schon Pharmaceuticals Limited?

The compliance status of Schon Pharmaceuticals Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available